Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women
What's New? Since the introduction of the human papillomavirus (HPV) vaccine in 2006, vaccine‐type infections have declined markedly. As nonvaccine HPV types generally carry lower oncogenic potential, this shift warrants reevaluation of cervical screening regimens.
Mònica Ortega Llobet +10 more
wiley +1 more source
The Short-Term Impacts of Japan's 2024 Physician Working-Hour Limits on Labor Conditions, Self-Directed Professional Development, and Happiness Among Obstetrician-Gynecologists. [PDF]
Maeda Y +27 more
europepmc +1 more source
Fertility preservation in women with sarcoma: A real‐world experience
What's New? Sarcomas frequently affect adolescent girls and young women, but limited data exist on ovarian function following sarcoma treatment. This observational cohort study evaluated the feasibility, timing, and clinical relevance of fertility preservation in young women treated for high‐grade sarcomas or desmoid tumors.
Guillaume Beinse +11 more
wiley +1 more source
Editorial Expression of Concern: Carbetocin versus syntometrine in the management of third stage of labor following vaginal delivery. [PDF]
Askar AA +3 more
europepmc +1 more source
Doppel as an early‐stage biomarker promoting EMT and dissemination in ovarian cancers
What's New? Existing biomarkers for ovarian cancer (OC) lack the sensitivity and specificity needed to consistently distinguish the malignancy from non‐ovarian influences and other cancers. Here, the authors explored the ability of the prion‐like protein Doppel, normally found in the male testes, to detect OC.
Zulfikar Azam +18 more
wiley +1 more source
Maintenance therapy after first-line therapy for ovarian cancer: Quantitative effectiveness. [PDF]
Campos SM, DiSilvestro J, Blank SV.
europepmc +1 more source
Adverse effects of maternal lead levels on birth outcomes in the ALSPAC study:a prospective birth cohort study [PDF]
Emond, Alan M +2 more
core +1 more source
What's New? High‐grade serous ovarian carcinoma is often diagnosed at advanced stages due to non‐specific symptoms and the lack of reliable screening methods. This proof‐of‐concept study introduces a novel TP53 mutation panel using unique molecular identifier‐based next‐generation sequencing for sensitive detection of high‐grade serous ovarian ...
Amanda Olsson Widjaja +11 more
wiley +1 more source
Correction: Effect of orally administered L. crispatus M247 in favoring HR-HPV clearance and CST shift: results from a randomized, multi-center, placebo-controlled trial. [PDF]
Di Pierro F +17 more
europepmc +1 more source

